These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 17936557)

  • 1. Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia.
    Guasch G; Schober M; Pasolli HA; Conn EB; Polak L; Fuchs E
    Cancer Cell; 2007 Oct; 12(4):313-27. PubMed ID: 17936557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keeping order in the neighborhood: new roles for TGFbeta in maintaining epithelial homeostasis.
    Wakefield LM; Stuelten C
    Cancer Cell; 2007 Oct; 12(4):293-5. PubMed ID: 17936552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype.
    Bharathy S; Xie W; Yingling JM; Reiss M
    Cancer Res; 2008 Mar; 68(6):1656-66. PubMed ID: 18339844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.
    Cohen J; Chen Z; Lu SL; Yang XP; Arun P; Ehsanian R; Brown MS; Lu H; Yan B; Diallo O; Wang XJ; Van Waes C
    Cancer Res; 2009 Apr; 69(8):3415-24. PubMed ID: 19351843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling.
    Achyut BR; Bader DA; Robles AI; Wangsa D; Harris CC; Ried T; Yang L
    PLoS Genet; 2013; 9(2):e1003251. PubMed ID: 23408900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner.
    Andl CD; McCowan KM; Allison GL; Rustgi AK
    Neoplasia; 2010 Jun; 12(6):485-98. PubMed ID: 20563251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris.
    Doi H; Shibata MA; Kiyokane K; Otsuki Y
    J Dermatol Sci; 2003 Oct; 33(1):7-16. PubMed ID: 14527734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761.
    Connolly EC; Saunier EF; Quigley D; Luu MT; De Sapio A; Hann B; Yingling JM; Akhurst RJ
    Cancer Res; 2011 Mar; 71(6):2339-49. PubMed ID: 21282335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells.
    Turco A; Coppa A; Aloe S; Baccheschi G; Morrone S; Zupi G; Colletta G
    Int J Cancer; 1999 Jan; 80(1):85-91. PubMed ID: 9935236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma.
    Andl T; Le Bras GF; Richards NF; Allison GL; Loomans HA; Washington MK; Revetta F; Lee RK; Taylor C; Moses HL; Andl CD
    Carcinogenesis; 2014 Nov; 35(11):2602-10. PubMed ID: 25233932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healing.
    Denton CP; Khan K; Hoyles RK; Shiwen X; Leoni P; Chen Y; Eastwood M; Abraham DJ
    J Invest Dermatol; 2009 Jan; 129(1):194-204. PubMed ID: 18563179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
    Amendt C; Schirmacher P; Weber H; Blessing M
    Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFβ signaling inhibits goblet cell differentiation via SPDEF in conjunctival epithelium.
    McCauley HA; Liu CY; Attia AC; Wikenheiser-Brokamp KA; Zhang Y; Whitsett JA; Guasch G
    Development; 2014 Dec; 141(23):4628-39. PubMed ID: 25377551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
    Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
    Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
    Owens DM; Watt FM
    Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibitory signalling by TGFbeta is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus.
    Jiang B; Zhang JS; Du J; Urrutia R; Barnard J
    Cell Signal; 2003 Jul; 15(7):699-708. PubMed ID: 12742230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of E-cadherin function drives the early stages of Ras-induced squamous cell carcinoma through upregulation of FAK and Src.
    Alt-Holland A; Sowalsky AG; Szwec-Levin Y; Shamis Y; Hatch H; Feig LA; Garlick JA
    J Invest Dermatol; 2011 Nov; 131(11):2306-15. PubMed ID: 21716326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of skin tumorigenesis in CD109-deficient mice.
    Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
    Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
    Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
    Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.
    Bhowmick NA; Chytil A; Plieth D; Gorska AE; Dumont N; Shappell S; Washington MK; Neilson EG; Moses HL
    Science; 2004 Feb; 303(5659):848-51. PubMed ID: 14764882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.